Nurosene Health Inc. announces appointment of new CFO
by CM Staff
Swapan Kakumanu has served at senior executive management levels, both in public and private companies in high growth technology, blockchain, manufacturing, trading and oil field services industries.
TORONTO — Nurosene Health Inc., a healthtech company focused on delivering AI-based technology solutions for mental performance and wellness, appoints financial executive Swapan Kakumanu as Chief Financial Officer.
“We are excited to welcome Swapan to our senior executive team. This appointment continues to demonstrate our commitment to building a world class management team. Swapan is a proven CFO with a great track record of delivering results in the capital market space. He will be a great addition to the Nurosene team and we look forward to the value that his skills can bring to the company.” said CEO of Nurosene, George Achilleos.
Mr. Kakumanu brings senior finance and operations experience. He has served at senior executive management levels, both in public and private companies in high growth technology, blockchain, manufacturing, trading and oil field services industries. He has held senior management roles as President, Chief Executive Officer and Chief Financial Officer where he has played a role in raising over $200 million through various financing vehicles, including debt, convertible debt, equity and other non-dilutive instruments both in the private and public markets. Mr. Kakumanu brings experience in public company reporting, investor relations, mergers and acquisitions, internal controls and general overall financial and operational management.